About Marcos Milla
Marcos Milla is a director at Enlaza Therapeutics.
Marcos Milla reports to the SEC as an officer of 1 public company: Synthorx (THOR).
Marcos Milla first appears on SEC filings in 2018.
Experience
This experience comes from SEC filings. The years are when the filings name Marcos Milla in the role, so the role may have started earlier or lasted longer.
SI
Synthorx, Inc.
Chief Scientific Officer
2018 – 2020 · Public company (THOR)
Key Colleagues at Startups
The people Marcos Milla works with at each company, as listed on that company's latest Form D.
Enlaza Therapeutics, Inc. · Form D, Sep 11, 2025
SS
Stephen Squinto
Director
TR
Tighe Reardon
Executive officer
JL
Jay Lichter
Director
SC
Shelley Chu
Director
SD
Sergio Duron
Chief Executive Officer and director
JT
James Topper
Director
SM
Sanford Madigan
Executive officer